Morton Capital Management LLC CA acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 390 shares of the healthcare conglomerate’s stock, valued at approximately $204,000.
Several other institutional investors also recently modified their holdings of the business. Fort Washington Investment Advisors Inc. OH boosted its position in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after acquiring an additional 1,465 shares during the last quarter. Waycross Partners LLC boosted its position in UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after acquiring an additional 658 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at $515,000. Full Sail Capital LLC boosted its position in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at $39,413,000. Institutional investors own 87.86% of the company’s stock.
Insider Buying and Selling
In other news, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kristen Gil bought 3,700 shares of the stock in a transaction on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company’s stock.
UnitedHealth Group Trading Down 1.6%
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company earned $6.91 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. The ex-dividend date is Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.82%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.
Analysts Set New Price Targets
Several brokerages have recently weighed in on UNH. JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a report on Thursday, May 15th. Oppenheimer dropped their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. Wells Fargo & Company reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Friday, June 6th. Wolfe Research dropped their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $426.52.
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- The Basics of Support and Resistance
- RH Stock Rockets on Surprise Profit and Tariff Shift
- What is a SEC Filing?
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- Investing in Travel Stocks Benefits
- Alphabet Enters a Bull Market: Is It Time to Buy?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.